OTC Markets OTCQB - Delayed Quote USD

InnoCan Pharma Corporation (INNPF)

Compare
0.1055 0.0000 (0.00%)
At close: October 18 at 4:00 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
24,388.0000
--
2,559.0000
196.0000
8.0000
--
Cost of Revenue
2,436.0000
--
452.0000
75.0000
5.0000
--
Gross Profit
21,952.0000
--
2,107.0000
121.0000
3.0000
--
Operating Expense
24,732.0000
--
8,373.0000
7,601.0000
4,728.0000
3,001.0000
Operating Income
-2,780.0000
--
-6,266.0000
-7,480.0000
-4,725.0000
-3,001.0000
Net Non Operating Interest Income Expense
11.0000
--
19.0000
-13.0000
-8.0000
-334.0000
Other Income Expense
574.0000
--
2,359.0000
-2,598.0000
-5,220.0000
--
Pretax Income
-2,195.0000
--
-3,888.0000
-10,091.0000
-9,953.0000
-3,335.0000
Tax Provision
926.0000
--
1.0000
--
--
--
Net Income Common Stockholders
-4,340.0000
--
-3,764.0000
-10,047.0000
-9,953.0000
-3,335.0000
Diluted NI Available to Com Stockholders
-4,340.0000
--
-3,764.0000
-10,047.0000
-9,953.0000
-3,335.0000
Basic EPS
-0.01
-0.02
-0.02
-0.05
-0.06
--
Diluted EPS
-0.01
-0.02
-0.02
-0.05
-0.06
--
Basic Average Shares
268,980.2960
257,003.7750
248,953.2200
224,541.7800
162,021.6510
--
Diluted Average Shares
268,980.2960
257,003.7750
248,953.2200
224,541.7800
162,021.6510
--
Total Operating Income as Reported
-2,780.0000
--
-6,266.0000
-7,480.0000
-4,725.0000
-3,001.0000
Rent Expense Supplemental
--
--
198.0000
84.0000
--
--
Total Expenses
27,168.0000
--
8,825.0000
7,676.0000
4,733.0000
3,001.0000
Net Income from Continuing & Discontinued Operation
-4,340.0000
--
-3,764.0000
-10,047.0000
-9,953.0000
-3,335.0000
Normalized Income
-4,827.9000
--
-5,504.7061
-7,449.0000
-4,733.0000
-3,335.0000
Interest Income
11.0000
--
21.0000
--
--
--
Interest Expense
--
--
2.0000
13.0000
8.0000
334.0000
Net Interest Income
11.0000
--
19.0000
-13.0000
-8.0000
-334.0000
EBIT
-2,195.0000
--
-3,886.0000
-10,078.0000
-9,945.0000
-3,001.0000
EBITDA
-2,158.0000
--
-3,851.0000
-10,035.0000
-9,905.0000
-2,978.0000
Reconciled Cost of Revenue
2,436.0000
--
452.0000
75.0000
5.0000
--
Reconciled Depreciation
37.0000
--
35.0000
43.0000
40.0000
23.0000
Net Income from Continuing Operation Net Minority Interest
-4,340.0000
--
-3,764.0000
-10,047.0000
-9,953.0000
-3,335.0000
Total Unusual Items Excluding Goodwill
574.0000
--
2,359.0000
-2,598.0000
-5,220.0000
--
Total Unusual Items
574.0000
--
2,359.0000
-2,598.0000
-5,220.0000
--
Normalized EBITDA
-2,732.0000
--
-6,210.0000
-7,437.0000
-4,685.0000
-2,978.0000
Tax Rate for Calcs
0.0002
--
0.0003
--
--
--
Tax Effect of Unusual Items
86.1000
--
618.2939
--
--
--
12/31/2019 - 11/27/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers